| Literature DB >> 32487101 |
Ting Zhang1,2, Huien Wang3, Xinling Wang1, Yue Yang1,2, Yingkui Zhang4, Zengjun Tang1, Li Wang5.
Abstract
BACKGROUND: The adverse pregnancy outcomes caused by teenage pregnancy are major public health problems with significant social impact. While China is the most populous country in the world, and 8.5% of the women aged 10-50 years are adolescent women, we aimed to analyze the adverse maternal and perinatal outcomes of the adolescent pregnancy in Hebei Province, China.Entities:
Keywords: Adolescent; Maternal outcomes; Perinatal outcomes; Pregnancy
Mesh:
Year: 2020 PMID: 32487101 PMCID: PMC7268722 DOI: 10.1186/s12884-020-03022-7
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Fig. 1The Flow Chart of Case Selection from 2013 to 2017, Hebei Province, China. Data of the pregnant women was collected from Hebei Province Maternal Near Miss Surveillance System (HBMNMSS)
Fig. 2Number and Percentage of Adolescent Pregnant Women in Hebei Province, China, from 2013 to 2017. Bar chart represents the number and line chart represents the percentage. Among the adolescent pregnant women, pregnant women ≤15 years was 88 (2.4%), 16 years was 174 (4.7%), 17 years was 428 (11.6%), 18 years was 979 (26.6%), 19 years was 2010 (54.6%)
Sociodemographic and Obstetric Characteristics of 238,598 Pregnant Women in Hebei Province, China
| 10–19 years | 20–34 years | F/χ2 | ||
|---|---|---|---|---|
| Marital status | ||||
| Married | 3492 (94.9) | 234,033 (99.6) | ||
| Single | 187 (5.1) | 886 (0.4) | 1791.693 | 0.000 |
| Education (year) | ||||
| ≤ 6 | 222 (6.1) | 4258 (1.8) | ||
| 7–9 | 2265 (62.2) | 79,550 (34.3) | ||
| 10–12 | 899 (24.7) | 70,870 (30.5) | ||
| > 12 | 253 (7.0) | 77,343 (33.3) | 1946.923 | 0.000 |
| Delivery place | ||||
| Tertiary Hospital | 950 (25.8) | 108,383 (46.1) | ||
| Secondary Hospital | 2722 (74.0) | 126,348 (53.8) | ||
| Primary Hospital | 0 (0.0) | 19 (0.0) | ||
| Home | 7 (0.2) | 163 (0.1) | 607.250 | 0.000 |
| Prenatal care | 5.6 (2.2) | 6.8 (2.4) | 889.906 | 0.000 |
| Parity | ||||
| 0 | 3328 (90.5) | 127,414 (54.3) | ||
| 1 | 315 (8.6) | 98,078 (41.8) | ||
| ≥ 2 | 35 (1.0) | 9324 (4.0) | 1918.563 | 0.000 |
| History of miscarriage | 421 (11.4) | 59,531 (25.4) | 372.160 | 0.000 |
| Chronic hypertension | 15 (0.4) | 1352 (0.6) | 1.790 | 0.181 |
| Gestational age (weeks) | 38.9 (1.9) | 38.9 (1.5) | 0.000 | 0.993 |
| Birth weight (g) | 3204 (509) | 3344 (491) | 292.171 | 0.000 |
Data of the pregnant women was collected from Hebei Province Maternal Near Miss Surveillance System (HBMNMSS) from 2013 to 2017. The values shown are n (%), Birth weight shown is mean (SD)
Adverse Maternal and Perinatal Outcomes of Pregnant Women in HBMNMSS from 2013 to 2017
| Outcomes | 10–19 years | 20–24 years | 25–34 years | F/χ2 | |
|---|---|---|---|---|---|
| ( | ( | ( | |||
| Cesarean delivery | 1439 (39.1) | 24,228 (45.4) | 94,563 (52.1) | 931.997 | 0.000 |
| Anemia | 900 (24.5) | 12,683 (23.8) | 48, 367 (26.6) | 182.959 | 0.000 |
| Gestational diabetes mellitus | 49 (1.3) | 1035 (1.9) | 7371 (4.1) | 596.689 | 0.000 |
| Preeclampsia | 95 (2.6) | 1360 (2.5) | 4287 (2.4) | 6.575 | 0.037 |
| HELLP syndrome | 5 (0.1) | 25 (0.0) | 144 (0.1) | 8.01 | 0.018 |
| Placenta previa | 7 (0.2) | 99 (0.2) | 825 (0.5) | 80.645 | 0.000 |
| Placental abruption | 11 (0.3) | 129 (0.2) | 477 (0.3) | 0.949 | 0.622 |
| Postpartum hemorrhage | 11 (0.3) | 135 (0.3) | 565 (0.3) | 4.726 | 0.094 |
| Maternal death | 1 (0.0) | 4 (0.0) | 3 (0.0) | 10.525 | 0.005 |
| Preterm delivery | 275 (7.5) | 2752 (5.2) | 9504 (5.2) | 37.638 | 0.000 |
| Small for gestational age | 528 (14.4) | 6507 (12.2) | 20,977 (11.6) | 40.595 | 0.000 |
| Lower Apgar at 5 min | 12 (0.3) | 136 (0.3) | 388 (0.2) | 4.953 | 0.084 |
| Stillbirth | 41 (1.1) | 221 (0.4) | 593 (0.3) | 68.637 | 0.000 |
| Neonatal death | 18 (0.5) | 121 (0.2) | 332 (0.2) | 20.49 | 0.000 |
Data of the pregnant women was collected from Hebei Province Maternal Near Miss Surveillance System (HBMNMSS) from 2013 to 2017. The values shown are n (%). HELLP syndrome: hemolysis, elevated liver enzymes, and low platelet count syndrome
Risks of Adverse Outcomes of Pregnant Women
| Outcomes | Maternal age (years) | 25–34 years old | |
|---|---|---|---|
| RR (95%CI) | aRR (95%CI) | ||
| Cesarean delivery | 10–17 | 0.54 (0.46–0.63)*** | 0.61 (0.52–0.71)*** |
| 18–19 | 0.60 (0.56–0.65)*** | 0.70 (0.65–0.76)*** | |
| 20–24 | 0.76 (0.75–0.78)*** | 0.87 (0.85–0.89)*** | |
| Anemia | 10–17 | 0.85 (0.71–1.02) | 1.01 (0.84–1.23) |
| 18–19 | 0.90 (0.83–0.98)* | 1.03 (0.95–1.12) | |
| 20–24 | 0.86 (0.84–0.88)*** | 0.95 (0.93–0.97)*** | |
| Gestational diabetes mellitus | 10–17 | 0.60 (0.37–0.97)* | 0.87 (0.54–1.44) |
| 18–19 | 0.26 (0.18–0.36)*** | 0.39 (0.28–0.56)*** | |
| 20–24 | 0.47 (0.44–0.50)*** | 0.60 (0.56–0.64)*** | |
| Pre-eclampsia | 10–17 | 0.98 (0.60–1.61) | 0.85 (0.51–1.40) |
| 18–19 | 1.12 (0.90–1.41) | 1.09 (0.87–1.38) | |
| 20–24 | 1.08 (1.02–1.15)* | 1.11 (1.03–1.18)** | |
| HELLP syndrome | 10–17 | – | – |
| 18–19 | 2.11 (0.87–5.15) | 2.91 (1.14–7.40)* | |
| 20–24 | 0.59 (0.39–0.90)* | 0.84 (0.54–1.32) | |
| Placenta previa | 10–17 | 0.96 (0.31–2.98) | 2.01 (0.64–6.38) |
| 18–19 | 0.29 (0.11–0.78)* | 0.73 (0.27–1.97) | |
| 20–24 | 0.41 (0.33–0.50)*** | 0.71 (0.57–0.90)** | |
| Placental abruption | 10–17 | 1.66 (0.53–5.17) | 1.76 (0.55–5.60) |
| 18–19 | 1.02 (0.51–2.05) | 1.30 (0.64–2.66) | |
| 20–24 | 0.92 (0.76–1.12) | 1.15 (0.93–1.42) | |
| Postpartum hemorrhage | 10–17 | 0.47 (0.07–3.31) | 0.55 (0.08–3.96) |
| 18–19 | 1.08 (0.58–2.01) | 1.49 (0.79–2.83) | |
| 20–24 | 0.81 (0.67–0.98)* | 1.03 (0.84–1.26) | |
| Maternal death | 10–17 | – | – |
| 18–19 | 20.25 (2.11–194.74)** | 11.02 (0.72–169.77) | |
| 20–24 | 4.53 (1.02–20.26)* | 5.01 (0.91–27.40) | |
| Preterm delivery | 10–17 | 2.08 (1.62–2.66)*** | 2.57 (1.98–3.34)*** |
| 18–19 | 1.33 (1.15–1.53)*** | 1.77 (1.51–2.06)*** | |
| 20–24 | 0.98 (0.94–1.03) | 1.26 (1.20–1.32)*** | |
| Small for gestational age | 10–17 | 1.22 (0.98–1.52) | 1.11 (0.89–1.39) |
| 18–19 | 1.30 (1.17–1.44)*** | 1.20 (1.08–1.33)*** | |
| 20–24 | 1.06 (1.03–1.09)*** | 1.00 (0.97–1.03) | |
| Low Apgar at 5 min | 10–17 | 2.82 (1.05–7.58)* | 2.87 (1.05–7.87)* |
| 18–19 | 1.26 (0.63–2.54) | 1.39 (0.68–2.83) | |
| 20–24 | 1.19 (0.98–1.45) | 1.31 (1.06–1.62)* | |
| Stillbirth | 10–17 | 8.17 (5.08–13.14)*** | 5.69 (3.36–9.65)*** |
| 18–19 | 2.37 (1.56–3.59)*** | 2.33 (1.50–3.60)*** | |
| 20–24 | 1.27 (1.09–1.48)*** | 1.45 (1.23–1.72)*** | |
| Neonatal death | 10–17 | 7.39 (3.79–14.38)*** | 7.57 (3.74–15.33)*** |
| 18–19 | 1.66 (0.85–3.21) | 2.03 (1.03–4.00)* | |
| 20–24 | 1.24 (1.01–1.53)* | 1.51 (1.21–1.90)*** | |
The pregnant women aged 25–34 years as the reference group. Adjusted by maternal education, marital status, delivery place, history of miscarriage, parity, previous cesarean delivery. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 3Forest Plots of Risks of Adverse Outcomes of Adolescent Pregnancy Compared with Adult Pregnancy. Compared with women (aged 25–34 years. Adjusted by maternal education, marital status, delivery place, history of miscarriage, parity, previous cesarean delivery
Fig. 4The Structural Equation Model of Risk Factors between Adolescent Pregnancy and Neonatal Death. The path coefficients was showed in figure
Risk of Adverse Pregnancy Outcomes in Adolescent Pregnancy Stratified by Parity
| Outcomes | Nulliparous ( | Multiparous ( | ||
|---|---|---|---|---|
| RR (95%CI) | aRR (95%CI) | RR (95%CI) | aRR (95%CI) | |
| Cesarean delivery | 0.73 (0.68–0.78)*** | 0.69 (0.65–0.75)*** | 0.55 (0.44–0.68)*** | 0.76 (0.57–1.02) |
| Anemia | 1.08 (1.00–1.17) | 1.10 (1.02–1.20)* | 0.80 (0.63–1.02) | 0.86 (0.67–1.10) |
| Gestational diabetes mellitus | 0.36 (0.27–0.48)*** | 0.59 (0.44–0.79)*** | 0.25 (0.08–0.77)* | 0.37 (0.12–1.16) |
| Pre-eclampsia | 1.08 (0.87–1.33) | 0.98 (0.79–1.21) | 0.39 (0.12–1.20)* | 0.46 (0.15–1.43) |
| HELLP syndrome | 2.00 (0.66–6.06) | 2.58 (0.96–6.90) | – | – |
| Placenta previa | 0.50 (0.19–1.35) | 0.76 (0.28–1.07) | 1.49 (0.48–4.66) | 2.60 (0.81–8.33) |
| Placental abruption | 1.41 (0.77–2.57) | 1.44 (0.77–2.69) | – | – |
| Postpartum hemorrhage | 1.10 (0.61–2.01) | 1.39 (0.75–2.58) | – | – |
| Maternal death | 9.57 (1.07–85.68)* | 2.14 (0.14–31.82) | – | – |
| Preterm delivery | 1.56 (1.37–1.77)*** | 1.67 (1.45–1.92)*** | 1.16 (0.75–1.79) | 1.34 (0.84–2.14) |
| Small for gestational age | 1.27 (1.15–1.39)*** | 1.22 (1.11–1.35)*** | 0.78 (0.54–1.12) | 0.72 (0.49–1.05) |
| Low Apgar at 5 min | 1.75 (0.98–3.12) | 1.57 (0.86–2.86) | – | – |
| Stillbirth | 3.83 (2.74–5.36)*** | 2.55 (1.76–3.71)*** | 2.15 (0.69–6.71) | 2.00 (0.64–6.31) |
| Neonatal death | 2.80 (1.71–4.59)*** | 2.72 (1.61–4.61)*** | 1.42 (0.20–10.12) | 1.57 (0.22–11.26) |
Adjusted by maternal education, marital status, delivery place, history of miscarriage, previous cesarean delivery. Women aged 20–34 years as the reference group. *P < 0.05, **P < 0.01, ***P < 0.001